Group of people talking

Results with Qelbree

Qelbree is an effective, safe*, and convenient once-a-day non-stimulant ADHD medication for adults and kids ages 6 years and older.

*Important: Monitor for mood or behavior changes. Your doctor should also monitor for changes in blood pressure and heart rate.

Proven results  

Safety profile  

Qelbree is proven to significantly reduce ADHD symptoms


By reducing the impact of ADHD symptoms, Qelbree can help with your everyday adulting that's complicated by your ADHD.

In the 6-week clinical trial, patients taking Qelbree met the goal of a significant reduction in ADHD symptom scores at the end of the study. For some patients, Qelbree reduced ADHD symptom scores as early as week 2.

Graph

In a 6-week study, Qelbree—a non-stimulant—was proven to help effectively reduce ADHD symptoms.

Clock

Rapid and extended release for full-day coverage.

Clinical Trial Results


How we ran the study:
Qelbree was studied in adults ages 18-60 who had been diagnosed with ADHD. 

The study measured what kind of changes in ADHD symptoms these adults experienced over the course of the clinical trial. They measured the frequency and severity of ADHD symptoms including inattention, hyperactivity, and impulsivity.

This was done using AISRS (Adult ADHD Investigator Symptom Rating Scale). This scale is the standard tool that helps measure the severity of symptoms over time. 

Arrow White

Qelbree showed a significant reduction in symptom scores compared to placebo

In a six-week clinical study, Qelbree was proven to reduce AISRS symptom severity scores.

Woman painting

Results you can feel


A 41% reduction at six weeks

Treatment with Qelbree resulted in a 41% decrease in symptoms from the start of the study, versus placebo which was 32%

In a randomized placebo-controlled flexible-dose trial with patients taking Qelbree 200-600mg


Adults talking Qelbree

Patients showed symptom score improvement each week of the study compared to placebo, starting at week 2

Checklist

Results your doctor can see

In a clinical study, physicians reported patients taking Qelbree had a greater improvement than patients receiving placebo. This was measured by the Clinical Global Impression Severity Scale (CGI-S)—a score physicians use to rate the observed severity of ADHD.

Physicians in the clinical study reported an improvement in the Clinical Global Impression Severity (CGI-S) scale – a score physicians use to rate the observed severity of ADHD on a medicine versus no medicine – at the end of the study.

Man smiling

I have the attention to help make my goals

achievable

Proven results  

Safety profile  

Qelbree is proven to be safe*, with manageable side effects


Qelbree was proven to be a safe* and effective treatment for ADHD, with a low incidence of side effects in a clinical trial.

*Important: Monitor for mood or behavior changes. Your doctor should also monitor for changes in blood pressure and heart rate.

The majority of these side effects did not cause patients to stop treatment with Qelbree.

Capsules

Qelbree is not a controlled substance and has no evidence for abuse or misuse.

Sometimes patients consider a planned break or "drug holiday" from a medication due to side effects or only take it “as needed” and not consistently. This is a conversation you should always have with your doctor before considering any kind of break.

Qelbree is unlikely to have negative interactions with stimulants like methylphenidate and amphetamine.

Most Common Side Effects

Side effect

Placebo

(183 people)

Qelbree

(189 people)

 

Difficulty sleeping (insomnia)§

7%

23%

Headacheǁ

7%

17%

Tiredness

3%

12%

Nausea

3%

12%

Decreased appetite

3%

10%

Dry mouth

2%

10%

Sleepiness

2%

6%

Constipation

1%

6%

§Insomnia included initial, middle and late insomnia, poor quality sleep, sleep disorder.

ǁHeadache: headache, migraine, migraine with aura, tension headache.

9.0% of participants taking Qelbree discontinued the clinical trial due to side effects vs 4.9% taking placebo.

Ready to talk to your doctor?

If you’re ready to ask about Qelbree, we’ve got your back.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in adults and children with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in adults and children with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you:
Take a medicine for depression called monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you. Qelbree may cause you to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in adults and children with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, in adults and children with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you:
Take a medicine for depression called monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you. Qelbree may cause you to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide including Boxed Warning.